Skip to main content
Premium Trial:

Request an Annual Quote

At Least They're Not Reading 'Sys Bio for Dummies'

Derek Lowe blogs about scientists reading business books, and what's so very wrong about that, in his opinion. "To be honest, I've always had a bit of a nervous feeling about anyone in the sciences who really seems to enjoy pop business books," he writes at In the Pipeline. "Most of the big sellers seem to be full of post hoc reasoning, sweeping statements that are backed up by weak or nonexistent evidence, and plenty of blatant padding." Whether scientists and business people will ever get along is questionable, but readers offer their two cents (in the comments) on who is most clueless when it comes to making science and business mesh.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.